TrialEmerging microbes & infections2026

Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.